CBU
NEO icon

CIBC Bancorp USA’s NeoGenomics NEO Stock Holding History

CIBC Bancorp USA’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$106K Buy
+13,753
New +$96.3K ﹤0.01% 1350

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CIBC Bancorp USA's NEO Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in NeoGenomics (NEO) in Q3 2025: 13,753 shares worth $106K. The stake represents ﹤0.01% of the portfolio and ranks #1350 among its holdings.

254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • CIBC Bancorp USA held 13,753 shares of NeoGenomics worth $106K as of Q3 2025.
  • NeoGenomics was a new CIBC Bancorp USA position in Q3 2025.
  • NeoGenomics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1350 holding.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.